expert perspectives

in Tardive Dyskinesia

Expert Perspectives in Tardive Dyskinesia to Cover Key Topics in Tardive Dyskinesia Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Tardive Dyskinesia will feature community-selected experts and topics in Tardive Dyskinesia that we hope you will find of value in your clinical practice.


VIEW THE TOPICS

Expert Roundtables 

  • Choosing the Right Treatment for Tardive Dyskinesia
  • Competing Theories of the Pathophysiology of Tardive Dyskinesia
  • Degree of Reversibility of Tardive Dyskinesia
  • Practice Guidelines on Tardive Dyskinesia

Clinical Topic Updates

  • Antipsychotic Switching Strategies in Tardive Dyskinesia 
  • Clinical Trials, Long-term Follow-Up, and Experience With VMAT2 Inhibitors
  • Dopamine-Receptor Blocking Agent Exposure in the Pathophysiology of Tardive Dyskinesia 
  • Tardive Dyskinesia, Drug Induced Parkinsonism, and Anticholinergic Medication

Patient Care Perspectives 

  • Early Recognition of the Clinical Features of Tardive Dyskinesia
  • Prevalence Rates of Tardive Dyskinesia With Second-Generation Antipsychotics
  • Refractory or Difficult-to-Treat Tardive Dyskinesia
  • Tardive Dyskinesia in Older Patients or Patients With Poor Insight Into Tardive Dyskinesia Symptoms

More In Psychiatry

Schizophrenia

Reducing Cardiometabolic Risk In Patients With Serious Psychiatric Illness

Expert Roundtables by Leslie Citrome, MD, MPH; John M. Kane, MD; and Jonathan M. Meyer, MD

Schizophrenia

Individualizing Pharmacotherapy For Patients With Schizophrenia And Their Comorbidities

Expert Roundtables by Leslie Citrome, MD, MPH; John M. Kane, MD; and Jonathan M. Meyer, MD

Schizophrenia

Functional Level In Schizophrenia Post Stabilization With Antipsychotic Medication

Patient Care Perspectives by Leslie Citrome, MD, MPH